Arcus Biosciences, Inc. (RCUS) Social Stream
ARCUS BIOSCIENCES INC (RCUS) Price Targets From Analysts
Use the tables below to see what analysts covering ARCUS BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 8 | $70 | $50 | $59.833 | $19.72 | 203.41% |
| 2021-11-17 | 8 | $70 | $48 | $58.142 | $19.72 | 194.84% |
| 2021-11-18 | 8 | $100 | $48 | $62.714 | $19.72 | 218.02% |
| 2021-11-22 | 9 | $100 | $48 | $64.857 | $19.72 | 228.89% |
| 2022-02-24 | 7 | $100.001 | $53 | $67 | $19.72 | 239.76% |
| 2022-04-12 | 7 | $100.001 | $53 | $68 | $19.72 | 244.83% |
| 2022-05-10 | 7 | $77 | $53 | $63.143 | $19.72 | 220.2% |
| 2022-05-13 | 7 | $77 | $42 | $59.571 | $19.72 | 202.08% |
| 2022-07-08 | 7 | $66 | $42 | $55.714 | $19.72 | 182.53% |
| 2022-08-04 | 7 | $60 | $36 | $50.428 | $19.72 | 155.72% |
| 2022-08-18 | 7 | $60 | $36 | $48.571 | $19.72 | 146.3% |
| 2022-08-31 | 8 | $60 | $36 | $48.875 | $19.72 | 147.84% |
| 2022-10-11 | 9 | $60 | $36 | $47.875 | $19.72 | 142.77% |
| 2022-10-14 | 8 | $60 | $36 | $45.285 | $19.72 | 129.64% |
| 2022-11-03 | 7 | $60 | $36 | $45.125 | $19.72 | 128.83% |
| 2022-11-18 | 7 | $51 | $33 | $41.75 | $19.72 | 111.71% |
| 2022-11-23 | 8 | $51 | $33 | $41.375 | $19.72 | 109.81% |
| 2022-12-20 | 9 | $51 | $24 | $40.875 | $19.72 | 107.28% |
| 2022-12-22 | 9 | $51 | $36 | $42.375 | $19.72 | 114.88% |
| 2023-01-09 | 9 | $51 | $36 | $42.375 | $19.72 | 114.88% |
| 2023-03-01 | 9 | $51 | $24 | $40.875 | $19.72 | 107.28% |
| 2023-03-02 | 9 | $51 | $23 | $40.75 | $19.72 | 106.64% |
| 2023-05-10 | 9 | $51 | $23 | $40.5 | $19.72 | 105.38% |
| 2023-05-15 | 9 | $51 | $22 | $40.375 | $19.72 | 104.74% |
| 2023-08-08 | 9 | $51 | $22 | $40.5 | $19.72 | 105.38% |
| 2023-08-21 | 9 | $51 | $21 | $40.125 | $19.72 | 103.47% |
| 2023-08-23 | 10 | $70 | $21 | $43.444 | $19.72 | 120.3% |
| 2023-08-24 | 10 | $70 | $21 | $43.777 | $19.72 | 121.99% |
| 2023-09-05 | 10 | $70 | $23 | $44 | $19.72 | 123.12% |
The Trend in the Analyst Price Target
Over the past 39 months, RCUS's average price target has gone up $6.
Over the past 47 weeks, RCUS's average upside potential has been 98.75%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-03 | 7 | 60 | 36 | 45.125 | 24.37 | 85.17% |
| 2022-11-03 | 8 | 60 | 36 | 45.125 | 24.37 | 85.17% |
| 2022-11-18 | 8 | 51 | 33 | 41.750 | 27.31 | 52.87% |
| 2023-06-02 | 9 | 51 | 22 | 40.500 | 21.01 | 92.77% |
| 2023-08-07 | 9 | 51 | 22 | 40.500 | 18.21 | 122.41% |
RCUS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 9 | 0 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
RCUS's average broker recommendation rating worsened by 0.09 over the prior 48 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ARCUS BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 3080.46% of all US stocks.
- In terms of how ARCUS BIOSCIENCES INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2383.96% of that group.
- ARCUS BIOSCIENCES INC's average analyst price target is greater than 2631.04% of Pharmaceutical Products stocks.
- ARCUS BIOSCIENCES INC's number of analysts covering the stock is higher than 2120.14% of stocks in the mid market cap category.
Stocks similar to ARCUS BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ZYME, HCM, and ORGO.
View All Top Stocks by Price Target
Is RCUS a Buy, Hold or Sell? See the POWR Ratings now!